CH589596A5 - - Google Patents

Info

Publication number
CH589596A5
CH589596A5 CH1350973A CH1350973A CH589596A5 CH 589596 A5 CH589596 A5 CH 589596A5 CH 1350973 A CH1350973 A CH 1350973A CH 1350973 A CH1350973 A CH 1350973A CH 589596 A5 CH589596 A5 CH 589596A5
Authority
CH
Switzerland
Application number
CH1350973A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH589596A5 publication Critical patent/CH589596A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
CH1350973A 1972-09-20 1973-09-20 CH589596A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00290590A US3850952A (en) 1972-09-20 1972-09-20 5-oxo-1beta-cyclopentane heptanoic acid derivative

Publications (1)

Publication Number Publication Date
CH589596A5 true CH589596A5 (de) 1977-07-15

Family

ID=23116685

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1350973A CH589596A5 (de) 1972-09-20 1973-09-20

Country Status (7)

Country Link
US (1) US3850952A (de)
JP (1) JPS4969637A (de)
CH (1) CH589596A5 (de)
DE (1) DE2347172A1 (de)
FR (1) FR2208898B1 (de)
GB (1) GB1426773A (de)
NL (1) NL7312215A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965120A (en) * 1973-10-15 1976-06-22 Merck & Co., Inc. Prostaglandin E1 intermediate 3-carboxymethyl-4-methyl-2-1-carboxy-7-(loweralkoxy or aralkoxycarbonyl)-heptyl]-4-hydroxybutyric acid, γ-lactone, and processes of their preparation
DE2365101A1 (de) * 1973-12-21 1975-07-10 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
US4204999A (en) * 1976-02-20 1980-05-27 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Process for making bicyclic lactone derivatives for use as intermediates in the synthesis of prostaglandins
US4189596A (en) * 1976-05-24 1980-02-19 The Upjohn Company Preparing 2-arylalkanoic acid derivatives
US4169199A (en) * 1976-12-27 1979-09-25 Sagami Chemical Research Center Precursors for prostaglandin analogue and process for preparing the same
WO2006035800A1 (ja) 2004-09-30 2006-04-06 Arkray, Inc. 薄膜ヒータおよび分析用具
CN112358436B (zh) * 2020-11-19 2021-06-22 内蒙古源宏精细化工有限公司 一种1,2-环戊二甲酰亚胺的制备方法

Also Published As

Publication number Publication date
FR2208898B1 (de) 1978-03-24
US3850952A (en) 1974-11-26
JPS4969637A (de) 1974-07-05
NL7312215A (de) 1974-03-22
GB1426773A (en) 1976-03-03
FR2208898A1 (de) 1974-06-28
DE2347172A1 (de) 1974-03-28

Similar Documents

Publication Publication Date Title
JPS5330739B2 (de)
JPS4947332A (de)
FR2187682A1 (de)
FR2199705A5 (de)
JPS565870B2 (de)
JPS4935890U (de)
JPS5512564Y2 (de)
FR2172569A5 (de)
JPS4966202U (de)
JPS4899140U (de)
JPS4924170A (de)
JPS4929871U (de)
JPS4947838U (de)
CS159012B1 (de)
CH578118A5 (de)
CH574913A5 (de)
SE7207856L (de)
NL7311312A (de)
NL7306384A (de)
CH562124A5 (de)
CH580066A5 (de)
CH579803A5 (de)
CH579788A5 (de)
CH579692A5 (de)
CH564724A5 (de)

Legal Events

Date Code Title Description
PL Patent ceased